Dyslipidemia in childhood and adolescence: From screening to management

Elizabeth Yeung; Stephen R. Daniels; Sonali S. Patel

doi:10.1097/MED.0000000000000607

Dyslipidemia in childhood and adolescence: From screening to management

Elizabeth Yeung, Stephen R. Daniels, Sonali S. Patel

Research output: Contribution to journal › Review article › peer-review

9 Scopus citations

Abstract

Purpose of reviewTo summarize types of dyslipidemia frequently encountered during childhood and adolescence, with a focus on screening, diagnosis, and management.Recent findingsIt is important that screening for atherosclerotic cardiovascular disease (ASCVD) begin in childhood. Genetic testing allows for increased awareness of dyslipidemia and more targeted intervention. Pharmacologic treatment of pediatric dyslipidemias has a good safety profile and can reduce adult ASCVD risk.SummaryMuch of what is known about pediatric dyslipidemia has been extrapolated from adult data, but recently, there have been increasing investigations within the pediatric population to better guide diagnosis and management of these disorders.

Original language	English (US)
Pages (from-to)	152-158
Number of pages	7
Journal	Current Opinion in Endocrinology, Diabetes and Obesity
Volume	28
Issue number	2
DOIs	https://doi.org/10.1097/MED.0000000000000607
State	Published - Apr 1 2021
Externally published	Yes

Keywords

atherogenic
dyslipidemia
familial hypercholesterolemia
hypertriglyceridemia
hypertriglyceridemia
lipoprotein(a)
screening

ASJC Scopus subject areas

Internal Medicine
Endocrinology, Diabetes and Metabolism
Endocrinology
Nutrition and Dietetics

Access to Document

10.1097/MED.0000000000000607

Cite this

@article{aa08fc5fb30f49a68354cedd660d2f9b,

title = "Dyslipidemia in childhood and adolescence: From screening to management",

abstract = "Purpose of reviewTo summarize types of dyslipidemia frequently encountered during childhood and adolescence, with a focus on screening, diagnosis, and management.Recent findingsIt is important that screening for atherosclerotic cardiovascular disease (ASCVD) begin in childhood. Genetic testing allows for increased awareness of dyslipidemia and more targeted intervention. Pharmacologic treatment of pediatric dyslipidemias has a good safety profile and can reduce adult ASCVD risk.SummaryMuch of what is known about pediatric dyslipidemia has been extrapolated from adult data, but recently, there have been increasing investigations within the pediatric population to better guide diagnosis and management of these disorders.",

keywords = "atherogenic, dyslipidemia, familial hypercholesterolemia, hypertriglyceridemia, hypertriglyceridemia, lipoprotein(a), screening",

author = "Elizabeth Yeung and Daniels, {Stephen R.} and Patel, {Sonali S.}",

year = "2021",

month = apr,

day = "1",

doi = "10.1097/MED.0000000000000607",

language = "English (US)",

volume = "28",

pages = "152--158",

journal = "Current Opinion in Endocrinology, Diabetes and Obesity",

issn = "1752-296X",

publisher = "Lippincott Williams and Wilkins",

number = "2",

}

TY - JOUR

T1 - Dyslipidemia in childhood and adolescence

T2 - From screening to management

AU - Yeung, Elizabeth

AU - Daniels, Stephen R.

AU - Patel, Sonali S.

PY - 2021/4/1

Y1 - 2021/4/1

N2 - Purpose of reviewTo summarize types of dyslipidemia frequently encountered during childhood and adolescence, with a focus on screening, diagnosis, and management.Recent findingsIt is important that screening for atherosclerotic cardiovascular disease (ASCVD) begin in childhood. Genetic testing allows for increased awareness of dyslipidemia and more targeted intervention. Pharmacologic treatment of pediatric dyslipidemias has a good safety profile and can reduce adult ASCVD risk.SummaryMuch of what is known about pediatric dyslipidemia has been extrapolated from adult data, but recently, there have been increasing investigations within the pediatric population to better guide diagnosis and management of these disorders.

AB - Purpose of reviewTo summarize types of dyslipidemia frequently encountered during childhood and adolescence, with a focus on screening, diagnosis, and management.Recent findingsIt is important that screening for atherosclerotic cardiovascular disease (ASCVD) begin in childhood. Genetic testing allows for increased awareness of dyslipidemia and more targeted intervention. Pharmacologic treatment of pediatric dyslipidemias has a good safety profile and can reduce adult ASCVD risk.SummaryMuch of what is known about pediatric dyslipidemia has been extrapolated from adult data, but recently, there have been increasing investigations within the pediatric population to better guide diagnosis and management of these disorders.

KW - atherogenic

KW - dyslipidemia

KW - familial hypercholesterolemia

KW - hypertriglyceridemia

KW - lipoprotein(a)

KW - screening

UR - http://www.scopus.com/inward/record.url?scp=85102215473&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85102215473&partnerID=8YFLogxK

U2 - 10.1097/MED.0000000000000607

DO - 10.1097/MED.0000000000000607

M3 - Review article

C2 - 33394719

AN - SCOPUS:85102215473

SN - 1752-296X

VL - 28

SP - 152

EP - 158

JO - Current Opinion in Endocrinology, Diabetes and Obesity

JF - Current Opinion in Endocrinology, Diabetes and Obesity

IS - 2

ER -

Dyslipidemia in childhood and adolescence: From screening to management

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this